Gene therapy against hepatocellular carcinoma using p48 gene
Gene therapy against hepatocellular carcinoma using p48 gene
批准号:
13670529
负责人:
EJIMA Eri
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
双链RNA依赖蛋白激酶(PKR)是干扰素诱导的抗病毒作用的关键因子。鉴于P48与信号转导和转录激活因子1和2(STAT1和STAT2)一起是干扰素-α信号通路中不可缺少的介导者,我们研究了P48基因转导对HH-7人肝癌细胞PKR表达及其活性的影响。将P48基因表达的腺病毒载体或质粒载体分别感染或转染HU-7细胞,并与干扰素-α共同孵育,检测PKR在细胞中的表达和真核合成蛋白合成起始因子2(EIF2)α亚单位α的磷酸化。此外,抑制蛋白质翻译的活性取决于氯霉素乙酰转移酶(CAT)基因翻译或α-甲胎蛋白分泌的减少。p48过表达本身不能刺激PKR的表达。然而,联合干扰素-α治疗后,p48基因过表达可显著增加pKR的表达,增强eIF2mRNA的磷酸化,从而阻断CAT基因的翻译和内源性α的合成,而不影响其α的表达水平。
英文摘要
Double-stranded RNA-dependent protein kinase (PKR) is a key factor involved in interferon (IFN)-induced antiviral actions. Since p48, together with signal transducers and activators of transcription 1 and 2 (STAT1 and STAT2), is an indispensable mediator in IFN-α signaling pathways, we investigated the effect of p48 gene transduction on PKR expression and its activity in HuH-7 human hepatoma cells.HuH-7 cells were infected or transfected with p48 gene expression adenoviral vector or plasmid vector, respectively, and incubated with or without IFN-α, then PKR expression and phosphorylation of α-subunit of eukaryotic protein synthesis initiation factor-2 (eIF2 α) in the cells were examined. In addition, PKR activity inhibiting protein translation was determined by the decrease of chloramphenicol acetyltransferase (CAT) gene translation or α-fetoprotein secretion.p48 overexpression itself could not stimulate PKR expression. However, p48 overexpression in combination with interferon-α treatment caused a marked increase in PKR expression and augmented the phosphorylation of eIF2 α, by which the transfected CAT gene translation, as well as the endogenous α-fetoprotein synthesis, was blocked without affecting their mRNA levels.These results suggest that p48 gene transduction may provide a strategy to enhance the IFN-mediated PKR expression and its activity in hepatocytes.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoko Tamada, et al.: "p48 overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase (PKR) in human hepatoma cells"Journal of Hepatology. 37・4. 493-499 (2002)
Yoko Tamada 等人:“p48 过度表达增强人肝癌细胞中干扰素介导的双链 RNA 依赖性蛋白激酶 (PKR) 的表达和活性”《肝脏病学杂志》37·4 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoko Tamada, et al.: "p48 overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells"Journal of Hepatology. 37. 493-499 (2002)
Yoko Tamada 等人:“p48 过表达增强人肝癌细胞中干扰素介导的双链 RNA 依赖性蛋白激酶的表达和活性”《肝脏病学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoko Tamada, Kazuhiko Nakao, Yuji Nagayama, Keisuke Nakata, Tatsuki Ichikawa, Yosei Kawamata, Hiroki Ishikawa, Keisuke Hamasaki, Katsumi Eguchi, Nobuko Ishii: "p48 overexpression enhances interferon-medialed expression and activity of double-stranded RNA-
Yoko Tamada、Kazuhiko Nakao、Yuji Nagayama、Keisuke Nakata、Tatsuki Ichikawa、Yosei Kawamata、Hiroki Ishikawa、Keisuke Hamasaki、Katsumi Eguchi、Nobuko Ishii:“p48 过表达增强了干扰素介导的双链 RNA 的表达和活性
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaya Shigeno, et al.: "Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation"Oncogene. (in press). (2003)
Masaya Shigeno 等人:“干扰素-α 通过 DR5 上调和 NF-κB 失活使人肝癌细胞对 TRAIL 诱导的细胞凋亡敏感”Oncogene(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaya Shigeno, et al.: "Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation"Oncogene. 22. 1653-1662 (2003)
Masaya Shigeno 等人:“干扰素-α 通过 DR5 上调和 NF-κB 失活使人肝癌细胞对 TRAIL 诱导的细胞凋亡敏感”Oncogene。22. 1653-1662 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
海外基金